Shree Salasar Investments to Raise ₹323.75 Cr via Preferential Warrants

Up to 18,50,000 warrants convertible into equity shares at Rs 175 each. Potential funds raised: ₹323.75 crore.

Reader Takeaway: Capital infusion for growth; dilution risk looms pending shareholder nod.

What just happened (today’s filing)

Shree Salasar Investments Limited's Board of Directors has approved a preferential issue of up to 18,50,000 warrants. These warrants will be convertible into equity shares on a 1:1 basis at an issue price of ₹175 per warrant.

The total potential capital to be raised through this issuance amounts to ₹323.75 crore. The warrants are exercisable within 18 months from their allotment date.

This significant capital raise is subject to shareholder approval, which the company will seek by convening an Extra-Ordinary General Meeting (EGM).

Why this matters

This preferential issue represents a substantial capital infusion for Shree Salasar Investments. The funds could be critical for business expansion, strategic acquisitions, debt reduction, or strengthening the company's balance sheet.

However, the conversion of warrants into equity shares will increase the total number of outstanding shares, potentially leading to dilution for existing shareholders if they do not participate in the issuance.

The backstory (grounded)

The company had previously indicated its intention to raise funds through warrants. A Board Meeting on February 11, 2026, had already considered a proposal for issuing warrants, subject to shareholder approval.

This move follows strong financial performance. In Q3 FY26 (ended December 31, 2025), Shree Salasar Investments reported a significant revenue surge to ₹310.14 million from ₹121.37 million year-on-year. Net income also saw a substantial jump to ₹53.8 million from ₹13.29 million during the same period.

What changes now

• Increased Capital Base: The company will gain access to significant funds, enabling potential strategic initiatives.
• Potential Shareholder Dilution: Existing shareholders' stakes may be diluted upon conversion of warrants.
• Enhanced Financial Flexibility: The capital raised can provide greater financial maneuverability.
• Regulatory Pathway: The process involves obtaining shareholder and potentially other regulatory approvals.

Risks to watch

• Shareholder Approval: The EGM could result in shareholders voting against the preferential issue, halting the fundraising plan.
• Warrant Exercise: There's a risk that allottees may not fully exercise their warrants within the 18-month period.
• SEBI Pricing Guidelines: The final issue price must adhere to SEBI's ICDR Regulations, which mandate specific pricing methodologies (e.g., VWAP) to protect existing shareholders from unfair valuations.
• Execution Risk: Delays in obtaining necessary approvals or completing the allotment process.

Peer comparison

While Shree Salasar Investments operates in the investment and real estate sectors, direct listed peers with identical business models are not clearly defined in the search results. The company is part of the 'Finance - Investment' industry. Competitors mentioned in financial services include Gourmet Gateway, PH Capital, and Keynote Finl. Serv.

Context metrics (time-bound)

• For Q3 FY26 (ended December 31, 2025), Shree Salasar Investments reported consolidated revenue of ₹310.14 million.
• Consolidated net income for the nine months ended December 31, 2025, stood at ₹133.82 million.

What to track next

• The outcome of the Extra-Ordinary General Meeting (EGM) for shareholder approval of the preferential issue.
• Completion of the allotment of warrants to the identified investors.
• Any necessary regulatory approvals from SEBI or other bodies.
• The exercise of warrants into equity shares by the allottees and the subsequent increase in the company's equity base.
• The utilization of the raised funds and their contribution to business growth and financial performance.